New shot aims to help people with peanut allergy eat safely
NCT ID NCT07015996
Summary
This study is testing if a drug called tezepelumab, given as an injection, can improve the effectiveness of peanut oral immunotherapy (OIT). OIT is a treatment where people eat tiny, increasing amounts of peanut protein to build tolerance. The goal is to see if this combination helps people with peanut allergy safely eat more peanuts, even 12 weeks after stopping the treatment. The study will enroll 62 people aged 12 to 55 with a confirmed peanut allergy.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PEANUT ALLERGY are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Arkansas Children's Hospital Research Institute: Department of Pediatrics, Allergy & Immunology
Little Rock, Arkansas, 72202, United States
-
Boston Children's Hospital: Allergy and Asthma Program
Boston, Massachusetts, 02115, United States
-
Cincinnati Children's Hospital Medical Center: Division of Allergy and Immunology
Cincinnati, Ohio, 45229, United States
-
Icahn School of Medicine at Mount Sinai: Department of Pediatrics Allergy & Immunology
New York, New York, 10029-6574, United States
-
Johns Hopkins Children's Center: Department of Allergy & Immunology
Baltimore, Maryland, 21287, United States
-
Massachusetts General Hospital: Department of Medicine: Allergy & Clinical Immunology Unit
Boston, Massachusetts, 02114, United States
-
North Carolina Children's Hospital: Department of Pediatrics, Division of Allergy, Immunology and Rheumatology
Chapel Hill, North Carolina, 27599, United States
-
The University of Michigan: Division of Allergy and Clinical Immunology
Ann Arbor, Michigan, 48105, United States
-
University of California, Los Angeles: Department of Medicine, Division of Clinical Immunology and Allergy
Los Angeles, California, 90095, United States
-
University of Texas Southwestern Medical Center: Division of Allergy and Immunology
Dallas, Texas, 75390-9063, United States
Conditions
Explore the condition pages connected to this study.